Curative intent therapy of stage I-III non-small cell lung cancer: a patient-centered precision approach to assess, measure, and interpret benefits and harms.
Ha DM, New ML, Randhawa SK, Chan ED, Dempsey EC, Fuster MM, Lippman SM, Murphy JD, Rivera MP. Curative intent therapy of stage I-III non-small cell lung cancer: a patient-centered precision approach to assess, measure, and interpret benefits and harms. J Thorac Dis. 2025 Jul 31; 17(7):4473-4500.